Merrimack
Cambridge
About Merrimack
Merrimack Pharmaceuticals discovers, designs, and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. Their systems biology is to apply capabilities to build functional and predictive computational models of biological systems such as cell signaling networks.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $432.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (Jul 2018)
- Ticker: nasdaq:MACK
- Website: merrimack.com
- Phone: +1 617 720 8606
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/merrimack-190016 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.